Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene.

Article Details

Citation

Taylor RW, Singh-Kler R, Hayes CM, Smith PE, Turnbull DM

Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene.

Ann Neurol. 2001 Jul;50(1):104-7.

PubMed ID
11456298 [ View in PubMed
]
Abstract

We describe a 42-year-old man who presented with a progressive history of epilepsy, stroke-like episodes, bilateral optic atrophy, and cognitive decline. Investigation of his muscle biopsy revealed a specific defect in complex I activity. Subsequent analysis of the mitochondrial genome identified a novel heteroplasmic T10191C mutation in the ND3 gene. The mutation was present at lower levels in blood from the patient and unaffected maternal relatives and is the first pathogenic mitochondrial DNA mutation in the ND3 gene to be described.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
NADH-ubiquinone oxidoreductase chain 3P03897Details